A per ‐protocol initiation of sacubitril/valsartan in an advanced heart failure disease management programme in the Middle East Gulf Region
ConclusionsInitiating sacubitril/valsartan through a defined protocol selects for appropriate candidates and guides starting dose and titration. Overall, significant success can be achieved in replacing ACEI or ARB by sacubitril/valsartan in symptomatic heart failure with reduced ejection fraction patients.
Source: ESC Heart Failure - Category: Cardiology Authors: Bassam Atallah,
Ziad G. Sadik,
Mohamed Hisham,
Oussama Kalagieh,
Iman Hamour,
Guirgis Gabra,
Mosaad El Banna,
Medhat Soliman,
Antoine Cherfan,
Feras Bader Tags: Original Research Article Source Type: research
More News: Cardiology | Diovan | Heart | Heart Failure | Heart Transplant | Middle East Health | Potassium | Study | Transplant Surgery | Transplants | UAE Health